Fibclot

Human Fibrinogen (Fibclot) is a clotting factor used to manage bleeding disorders. This intravenous medication supports blood coagulation, crucial for surgical or trauma-related bleeding. Learn more about its uses and effects.

Human Fibrinogen, marketed as Fibclot, is primarily used to control bleeding in patients with congenital fibrinogen deficiency. It is often administered intravenously to support blood clotting during surgical procedures or in cases of severe trauma. This medication is designed to help manage bleeding episodes by replenishing fibrinogen levels in the bloodstream.

When administered, Human Fibrinogen works to enhance the body's natural clotting process. Patients may experience improved coagulation, reducing the risk of excessive bleeding. Common effects include localized reactions at the injection site, such as mild discomfort or swelling.

Human Fibrinogen should be used under medical supervision. Patients with a history of allergic reactions to fibrinogen or its components should avoid this medication. It is important to inform healthcare providers about any existing medical conditions or medications being taken to ensure safe administration.

Human Fibrinogen may interact with other medications that affect blood clotting. It is advisable to consult a healthcare provider before combining it with anticoagulants or antiplatelet drugs. Alcohol consumption should also be discussed with a medical professional to avoid potential adverse effects.